ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0017

Lessons Learnt from Associations Between Anti-modified Protein Antibodies and Risk Factors: Human Leukocyte Antigen – Shared Epitope Alleles Solely Associate with Anti-citrullinated Protein Antibodies

Tineke J van wesemael, Annemarie L. Dorjee, Tom WJ Huizinga, Annette H.M van der Helm-van Mil, René Toes and Diane van der Woude, Leiden University Medical Center, Leiden, Netherlands

Meeting: ACR Convergence 2021

Keywords: Autoantibody(ies), genetics, rheumatoid arthritis, risk factors, Smoking

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 6, 2021

Title: RA – Etiology & Pathogenesis Poster (0011–0045)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Rheumatoid arthritis (RA) is characterized by the presence of auto-antibodies to post translationally modified proteins (anti-modified protein antibodies (AMPA)): anti-citrullinated protein antibodies (ACPA), anti-carbamylated protein antibodies (anti-CarP) and anti-acetylated protein antibodies (AAPA). ACPA is unique since an association with the risk factors smoking and the human leukocyte antigen (HLA) – shared epitope (SE) is found only in the ACPA positive patients. However the association of SE and smoking with all three AMPA has remained unstudied. Nonetheless, this association is of great interest, since it would increase our understanding if the pathological mechanisms underlying the development of these auto-antibodies are unique of shared.

Objective: To investigate the association of SE and smoking with the different kinds of AMPA.

Methods: 648 RA patients fulfilling the 1987 RA criteria from the Leiden Early Arthritis Cohort, of whom data were available on the presence of ACPA, AAPA and anti-CarP, smoking and SE status were included. SE positivity was defined as having ≥1 of the following HLA alleles: DRB1*01:01, *01:02, *04:01, *04:04, *04:05, *04:08 and*10:01. Healthy controls (n=1211) for SE analysis were randomly selected from the collection of the section of Immunogenetics and Transplantation Immunology from the Leiden University Medical Center. The association between auto-antibodies and SE and smoking was assessed by logistic regression analysis.

Results: When investigating the association of smoking with the presence of the various combinations of AMPA, a significant association was only found in the triple positive patients (OR 1.67 (1.08 – 2.60), p0.02), table 1. There was no association with smoking for patients positive for one or two auto-antibodies.

SE was solely associated with ACPA positive patients, whereas the association with SE was similar among patients who were single-positive for ACPA compared to patients harboring 1 or 2 additional auto-antibodies (AAPA and/or anti-CarP), indicating that SE is only associated with ACPA.

Conclusion: This in-depth analysis of the exact association between risk factors and AMPA presence revealed striking differences regarding the associations for smoking versus SE. Since smoking is associated with the concurrent presence of multiple AMPA, this implies that smoking is involved in a general process of auto-antibody development. However SE is solely associated with the presence of ACPA, and not with anti-CarP or AAPA. This suggests that, despite the similarity in antigenic targets and partial cross reactivity between AMPA responses, the pathophysiological mechanisms underlying their development differ for the various AMPA.

Table 1 Association of smoking with anti-modified protein antibodies

Table 2 Association of SE with anti-modified protein antibodies


Disclosures: T. van wesemael, None; A. Dorjee, None; T. Huizinga, None; A. van der Helm-van Mil, None; R. Toes, None; D. van der Woude, None.

To cite this abstract in AMA style:

van wesemael T, Dorjee A, Huizinga T, van der Helm-van Mil A, Toes R, van der Woude D. Lessons Learnt from Associations Between Anti-modified Protein Antibodies and Risk Factors: Human Leukocyte Antigen – Shared Epitope Alleles Solely Associate with Anti-citrullinated Protein Antibodies [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/lessons-learnt-from-associations-between-anti-modified-protein-antibodies-and-risk-factors-human-leukocyte-antigen-shared-epitope-alleles-solely-associate-with-anti-citrullinated-protein-antibodies/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lessons-learnt-from-associations-between-anti-modified-protein-antibodies-and-risk-factors-human-leukocyte-antigen-shared-epitope-alleles-solely-associate-with-anti-citrullinated-protein-antibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology